D-Day
The Part D donut hole has arrived, and pharma is scrambling to maintain brand loyalty.
Fast Forward
A new, faster recipe for drug development: Chat up regulators. Outsource where you can. And know when to let go.
Shire, Barr Swap Drugs, Not Money
The recent settlement between branded and generic companies offers a 'win-win' approach to patent challenges.
